000 | 01009 a2200313 4500 | ||
---|---|---|---|
005 | 20250511165427.0 | ||
264 | 0 | _c19760209 | |
008 | 197602s 0 0 eng d | ||
022 | _a0001-7604 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSvestka, J | |
245 | 0 | 0 |
_aThe position of trifluoperazine in the group of neuroleptics (a controlled clinical comparative study). _h[electronic resource] |
260 |
_bActivitas nervosa superior _cSep 1975 |
||
300 |
_a208 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPerphenazine _xtherapeutic use |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 |
_aTrifluoperazine _xtherapeutic use |
700 | 1 | _aNáhunek, K | |
700 | 1 | _aRodová, A | |
700 | 1 | _aCesková, E | |
773 | 0 |
_tActivitas nervosa superior _gvol. 17 _gno. 3 _gp. 208 |
|
999 |
_c1113327 _d1113327 |